Brokerages Set Surgery Partners, Inc. (NASDAQ:SGRY) Price Target at $40.71

Surgery Partners, Inc. (NASDAQ:SGRYGet Free Report) has been given an average rating of “Moderate Buy” by the eight analysts that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $38.71.

A number of research firms have weighed in on SGRY. Royal Bank of Canada decreased their target price on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research report on Wednesday, November 20th. KeyCorp assumed coverage on shares of Surgery Partners in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. UBS Group initiated coverage on shares of Surgery Partners in a research report on Monday, October 14th. They issued a “buy” rating and a $38.00 price target for the company. Macquarie reiterated an “outperform” rating and set a $34.00 price target on shares of Surgery Partners in a research note on Tuesday, November 19th. Finally, StockNews.com lowered shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th.

Check Out Our Latest Report on Surgery Partners

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Quarry LP grew its holdings in Surgery Partners by 133.1% in the second quarter. Quarry LP now owns 3,082 shares of the company’s stock valued at $73,000 after purchasing an additional 1,760 shares during the last quarter. KBC Group NV grew its stake in Surgery Partners by 31.8% in the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock valued at $77,000 after acquiring an additional 576 shares during the last quarter. DekaBank Deutsche Girozentrale grew its stake in Surgery Partners by 102.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after acquiring an additional 1,375 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. increased its holdings in Surgery Partners by 747.6% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock valued at $124,000 after acquiring an additional 3,379 shares in the last quarter. Finally, EntryPoint Capital LLC raised its position in Surgery Partners by 257.1% during the first quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock worth $191,000 after acquiring an additional 4,607 shares during the last quarter.

Surgery Partners Trading Up 1.7 %

Shares of NASDAQ SGRY opened at $23.39 on Tuesday. The stock has a fifty day simple moving average of $29.86 and a 200-day simple moving average of $28.36. Surgery Partners has a twelve month low of $21.36 and a twelve month high of $36.92. The stock has a market capitalization of $2.97 billion, a PE ratio of -49.27, a PEG ratio of 19.15 and a beta of 2.76. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99.

Surgery Partners (NASDAQ:SGRYGet Free Report) last released its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm had revenue of $770.40 million for the quarter, compared to analysts’ expectations of $768.99 million. During the same quarter in the previous year, the company posted $0.15 earnings per share. The firm’s quarterly revenue was up 14.3% on a year-over-year basis. On average, equities analysts forecast that Surgery Partners will post 0.73 earnings per share for the current year.

About Surgery Partners

(Get Free Report

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Further Reading

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.